Charles Loprinzi on Chemotherapy-Induced Peripheral Neuropathy

Article

Charles Loprinzi, MD, Mayo Clinic, discusses managing chemotherapy-induced peripheral neuropathy in adult patients with cancer.

Charles Loprinzi, MD, Mayo Clinic, discusses managing chemotherapy-induced peripheral neuropathy in adult patients with cancer.

When patients present with symptoms of chemotherapy-induced neuropathy, healthcare professionals need to weigh the benefits of continuing therapy.

Loprinzi says that he tends to stop treatment early in patients with neuropathy in order to prevent the condition from becoming chronic.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.